Politics & policy
Lung Cancer Screening
Legislation & regulation
Pharm D Corner
Esperoct Approved for Treatment of Hemophilia A in Adults and Children
Disease Occurs in 1 in 5,000 Male Births in the U.S.
New Robotic Aid for Drugfree Depression Treatment
Non-Invasive Therapy for Patients Who are Nonresponsive to Antidepressants
Dwindling Supplies of Critical Cancer Drug BCG
Vials Being Rationed, Only One Manufacturer
Deep Brain Stimulation for Medically Refractory Epilepsy Launched in U.S.
Several Health Insurers Now Consider DBS Therapy for Epilepsy a Covered Indication
Finally! Some Details About the Amazon, Berkshire Hathaway, and J.P. Morgan Chase Project
The main goal of Atul Gawande’s effort: Make health care intelligible.
Blood Plasma Alert: Don’t Be Fooled
FDA warns of scheme in which the blood plasma of the young is sold as a cure for dementia, Parkinson’s, and other maladies.
Verdiperstat Receives Orphan Drug Designation for Fatal, Fast-Acting Neurodegenerative Disease
Drug Has Potential Role In Oxidative Stress, Inflammation, and Neurodegeneration
Obeticholic Acid Could Become First Approved Medicine for Liver Fibrosis From NASH
OCA Meets Primary Endpoint of Improvement in Liver Fibrosis
Melbourne University Student Discovers ‘Killer’ T-Cells That Can Fight Multiple Influenza Virus Strains
Breakthrough Offers Potential for Universal, One-Shot Flu Vaccine
Type of MRI Scan is a Potential Biomarker for Psychosis
Scan Could Improve Understanding of Dopamine Function in Schizophrenia
Breakthrough Blood Test for Pain Could Help Stanch Opioid Crisis
Test Determines Severity of Pain, Helps Physicians Select Best Options
Oncology Drug PV-10 Gets Orphan Drug Status for Ocular Melanoma
Intratumoral Injection Stimulates Immune Activation
Egaten Approved for the Treatment of Tropical Disease Fascioliasis
Liver Fluke Infestation Affects Almost 2.5 Million People Globally
Cigna First Private Insurer to Consider Exoskeleton Device Coverage
Policy Could Be Life-Changing for People With Spinal Cord Injury
HHS Chief Alex Azar Hears Physician Concern About Step Therapy
Doctors at an AMA conference express worry that any such move would hurt patients.
FDA’s Gottlieb Aims To End Biosimilars Groundhog Day
A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity
Bringing Humira (Its Price) Down a Peg
Why Biosimilars Can Never Be Identical To Originators–and Why They Don’t Need To Be
Show Us (the U.S.) the Savings
View More >
Terms & Conditions of Use Agreement
Address and Subscription Changes
Managed Care News Archive
2019 Editorial Calendar
2019 Media Kit
2018 Media Kit
2019 Space and Material Due Dates
Submitting Original Research
© 2019 MediMedia, an ICON plc company. All rights reserved.